[url="]Agenus[/url] Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that three-year survival data from the Phase 1b C-800-01 study

Maison Solutions Inc. Class A Common Stock (MSS) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q3
the company's inability to maintain positive net income, which reached -$5.2 million in 2026Q3, alongside a precarious current ratio of 0.67, suggests a high risk of insolvency.
Maison Solutions Inc. Class A Common Stock (MSS) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Recent stock market news and headlines for Maison Solutions Inc. Class A Common Stock (MSS)
[url="]Agenus[/url] Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that three-year survival data from the Phase 1b C-800-01 study

Key metrics vs top competitors for Maison Solutions Inc. Class A Common Stock (MSS)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $0.65 | $1.37M | 0.99 | 114.01% | 0.94% | 10.46% | — | |
| $31.46 | $724.86M | 15.73 | 7.19% | 3.6% | 22.26% | — | |
| $42.21 | $625.09M | 11.05 | 3.76% | 2.27% | 10.74% | — | |
| $95.29 | $3.89B | 56.72 | 9.36% | 1.87% | 13.54% | — | |
| $112.65 | $17.7B | 51.67 | 8.61% | 0.49% | 7.13% | — | |
| $81.85 | $7.7B | 15.41 | 14.08% | 5.7% | 36.06% | — |
Maison Solutions Inc. Class A Common Stock (MSS) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Get notified when MSS posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Maison Solutions Inc. Class A Common Stock (MSS) stock FAQ — growth, dividends, profitability & financials explained
Maison Solutions Inc. Class A Common Stock (MSS) reported $113.7M in revenue for fiscal year 2025. This represents a 176% increase from $41.2M in 2021.
Maison Solutions Inc. Class A Common Stock (MSS) grew revenue by 114.0% over the past year. This is strong growth.
Maison Solutions Inc. Class A Common Stock (MSS) reported a net loss of $12.0M for fiscal year 2025.
Maison Solutions Inc. Class A Common Stock (MSS) has a return on equity (ROE) of 10.5%. This is reasonable for most industries.
Maison Solutions Inc. Class A Common Stock (MSS) had negative free cash flow of $0.7M in fiscal year 2025, likely due to heavy capital investments.